Centre hospitalier universitaire de Sherbrooke

Sherbrooke, Quebec JiH 5N4

2 studies enrolling now · 42 studies all time

What they study most

ARDS, Acute Lung Injury, Acute Myocardial Infarction, Acute Respiratory Distress Syndrome, Acute T Cell Leukemia Lymphoma, Anemia, Angina Pectoris, Angioplasty, Transluminal, Percutaneous Coronary, AtrioVentricular Nodal Reentrant Tachycardia, Bladder Cancer, Bone Cancer, Bone Metastases

Studies at this site

• AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia — Recruiting now
• Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study — Recruiting now
• The Dragon PLC Trial (DRAGON-PLC) — Recruiting now
• A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder — Running, not enrolling
• A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate — Running, not enrolling
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer — Running, not enrolling
• I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). — Completed
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium — Running, not enrolling
• Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia — Completed
• SAHaRA: A Randomized Controlled Trial — Completed
• Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial — Completed
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — Completed
• Antiarrhythmics or Ablation for Ventricular Tachycardia 2 — Completed
• Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV — Status unconfirmed
• Myocardial Ischemia and Transfusion — Completed
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer — Completed
• Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma — Completed
• Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity — Completed
• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) — Completed
• Ultra-Low Tidal Volume Mechanical Ventilation in ARDS Through ECMO — Status unconfirmed
• Dose-response Relationship Study of S42909 on Leg Ulcer Healing — Completed
• Syncope: Pacing or Recording in the Later Years — Completed
• Optimal VAsopressor titraTION Pilot Randomized Controlled Trial — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Transfusion Requirements in Cardiac Surgery III — Completed
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) — Completed
• Alipogene Tiparvovec for the Treatment of LPLD Patients — Withdrawn before enrolling
• Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer — Stopped early
• Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) — Completed
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy — NO_LONGER_AVAILABLE
• Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme — Stopped early
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed
• Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury — Completed